Skip to main navigation Skip to search Skip to main content

Investigation of the role of mesoderm inducing genes in a cell culture model for the progression of colorectal cancer

  • Debalina Sarkar

    Student thesis: Doctor of Philosophy

    Abstract

    Cancer stem cells (CSC) are initiating cells in many cancer types that have
    similar prope1ties like normal embryonic stem cells. Colorectal tumours can undergo epithelial to mesenchymal transition (EMT)-like processes at the invasive front, rendering them capable of invasion and metastasis. Recently, a possible link between cells undergoing EMT and cells with stem cell like properties has been identified in mammary Cancer stem cells (CSC). It is of fundamental importance to understand molecular events leading to establishment and maintenance of cancer initiating cells and how these relate to cellular transitions during tumourigenesis. However it is difficult to observe these processes in vivo, not least due to the transient nature of events during tumourigenesis.
    We used an in vitro system to recapitulate changes occuring in CRC cells at
    the invasive front (mesenchymal-like cells) and central mass (epithelial-like cells) of tumours. We show for the first time, that the mesoderm inducer BRACHYURY
    differentially influences expression of the pluripotency gene NANOG, through
    association of BRACHYURY with upstream regulatory e lements in the NANOG
    promoter in CRC cells. Binding ofBRACHYURY to the NANOG promoter directly
    influences expression of NANOG and is predominant in mesenchymal-like cancer
    cells. We also demonstrate that the oncogene, ~-catenin is upstream of both
    BRACHYURY and NANOG and influences the expression of markers of CSCs in the
    mesenchymal-like cells, whose presence has previously been linked to poor patient prognosis. Finally, we show that a similar pathway exists in two other cell lines (NTERA-2 and T84).
    Date of AwardMay 2010
    Original languageEnglish
    Awarding Institution
    • Bangor University
    SponsorsTenovus Cancer Researc & Gwynedd Haematology and Cancer Research Fund

    Cite this

    '